| Primary |
| Dry Eye |
50.0% |
| Intraoperative Care |
50.0% |
|
| Keratitis |
66.7% |
| Eye Irritation |
33.3% |
|
| Secondary |
| Ulcerative Keratitis |
39.7% |
| Fungal Infection |
19.0% |
| Eye Disorder |
15.9% |
| Anal Fungal Infection |
9.5% |
| Drug Use For Unknown Indication |
6.3% |
| Glaucoma |
3.2% |
| Surgery |
3.2% |
| Lacrimation Increased |
1.6% |
| Product Used For Unknown Indication |
1.6% |
|
| Eye Irritation |
18.2% |
| Toxic Skin Eruption |
18.2% |
| Vision Blurred |
18.2% |
| Glaucoma |
9.1% |
| Lacrimation Increased |
9.1% |
| Photophobia |
9.1% |
| Rash Maculo-papular |
9.1% |
| Tear Discolouration |
9.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.6% |
| Hypertension |
9.7% |
| Dry Eye |
8.0% |
| Chronic Obstructive Pulmonary Disease |
5.3% |
| Asthma |
4.4% |
| Drug Use For Unknown Indication |
4.2% |
| Pain |
3.8% |
| Medical Diet |
3.4% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Anxiety |
2.5% |
| Glaucoma |
2.5% |
| Multiple Sclerosis |
2.5% |
| Atrial Fibrillation |
2.3% |
| Hiv Infection |
2.3% |
| Osteoporosis |
2.3% |
| Pneumocystis Jiroveci Pneumonia |
2.3% |
| Rheumatoid Arthritis |
2.3% |
| Blood Cholesterol Increased |
2.1% |
| Arthritis |
1.9% |
| Parkinson's Disease |
1.9% |
|
| White Blood Cell Count Increased |
11.5% |
| Blood Amylase Increased |
6.4% |
| Eye Irritation |
6.4% |
| Wound Dehiscence |
6.4% |
| Aneurysm |
5.1% |
| Pain In Extremity |
5.1% |
| Urinary Incontinence |
5.1% |
| Urine Flow Decreased |
5.1% |
| Vision Blurred |
5.1% |
| Visual Acuity Reduced |
5.1% |
| Vitreous Floaters |
5.1% |
| Vomiting |
5.1% |
| Electrocardiogram Qt Prolonged |
3.8% |
| Eye Pain |
3.8% |
| Instillation Site Pain |
3.8% |
| Lacrimation Increased |
3.8% |
| Rash |
3.8% |
| Weight Decreased |
3.8% |
| Cerebral Thrombosis |
2.6% |
| Dry Skin |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
79.3% |
| Oropharyngeal Pain |
6.9% |
| Tongue Ulceration |
6.9% |
| Laryngitis |
3.4% |
| Plasma Cell Myeloma |
3.4% |
|
|
